Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 28%
May 28
Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedMay 31, 2025
DataAggregated Company Financials
Companies295
- 7D0.4%
- 3M11.1%
- 1Y20.4%
- YTD-6.2%
Over the last 7 days, the Healthcare industry has remained flat, although notably GlaxoSmithKline Pharmaceuticals gained 9.0%. The past year has been better, since the industry has gained 20% in that time. Earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 31 May 2025 | ₹29.0t | ₹5.3t | ₹725.0b | 35.3x | 39.9x | 5.4x |
| Mon, 28 Apr 2025 | ₹28.2t | ₹5.2t | ₹682.5b | 33.9x | 41.4x | 5.4x |
| Wed, 26 Mar 2025 | ₹28.3t | ₹5.2t | ₹680.1b | 33.2x | 41.6x | 5.4x |
| Fri, 21 Feb 2025 | ₹27.2t | ₹5.2t | ₹680.9b | 32x | 40x | 5.2x |
| Sun, 19 Jan 2025 | ₹28.6t | ₹5.0t | ₹649.1b | 36.7x | 44.1x | 5.7x |
| Tue, 17 Dec 2024 | ₹28.9t | ₹5.0t | ₹643.1b | 37.5x | 45x | 5.8x |
| Thu, 14 Nov 2024 | ₹27.9t | ₹5.0t | ₹633.9b | 38.9x | 44x | 5.6x |
| Sat, 12 Oct 2024 | ₹29.5t | ₹4.9t | ₹605.3b | 43.2x | 48.8x | 6.1x |
| Mon, 09 Sep 2024 | ₹28.8t | ₹4.9t | ₹605.2b | 42.1x | 47.6x | 5.9x |
| Wed, 07 Aug 2024 | ₹26.5t | ₹4.8t | ₹575.3b | 36.7x | 46.1x | 5.5x |
| Fri, 05 Jul 2024 | ₹24.7t | ₹4.6t | ₹548.9b | 36.6x | 45x | 5.3x |
| Sun, 02 Jun 2024 | ₹22.9t | ₹4.7t | ₹548.3b | 33.1x | 41.7x | 4.9x |
| Tue, 30 Apr 2024 | ₹23.2t | ₹4.6t | ₹512.4b | 36.1x | 45.2x | 5x |
| Thu, 28 Mar 2024 | ₹22.6t | ₹4.6t | ₹512.7b | 33.3x | 44.1x | 4.9x |
| Sat, 24 Feb 2024 | ₹23.3t | ₹4.6t | ₹511.9b | 36.4x | 45.5x | 5.1x |
| Mon, 22 Jan 2024 | ₹21.3t | ₹4.4t | ₹477.8b | 37.1x | 44.6x | 4.8x |
| Wed, 20 Dec 2023 | ₹19.9t | ₹4.4t | ₹476.2b | 34.7x | 41.7x | 4.5x |
| Fri, 17 Nov 2023 | ₹18.8t | ₹4.4t | ₹475.9b | 32.3x | 39.4x | 4.3x |
| Sun, 15 Oct 2023 | ₹18.2t | ₹4.3t | ₹452.3b | 32.6x | 40.2x | 4.3x |
| Tue, 12 Sep 2023 | ₹18.1t | ₹4.2t | ₹450.8b | 32.4x | 40.2x | 4.3x |
| Thu, 10 Aug 2023 | ₹18.1t | ₹4.2t | ₹443.1b | 30.6x | 40.8x | 4.3x |
| Sat, 08 Jul 2023 | ₹16.5t | ₹4.1t | ₹425.6b | 28.5x | 38.7x | 4x |
| Mon, 05 Jun 2023 | ₹15.2t | ₹4.1t | ₹425.6b | 27.9x | 35.7x | 3.7x |
| Wed, 03 May 2023 | ₹14.0t | ₹3.9t | ₹372.8b | 27.3x | 37.5x | 3.6x |
| Fri, 31 Mar 2023 | ₹13.2t | ₹3.9t | ₹372.9b | 24.5x | 35.3x | 3.4x |
| Sun, 26 Feb 2023 | ₹13.3t | ₹3.9t | ₹373.6b | 25.3x | 35.6x | 3.4x |
| Tue, 24 Jan 2023 | ₹13.9t | ₹3.7t | ₹377.8b | 28.6x | 36.8x | 3.7x |
| Thu, 22 Dec 2022 | ₹14.2t | ₹3.7t | ₹377.3b | 28.7x | 37.6x | 3.8x |
| Sat, 19 Nov 2022 | ₹14.1t | ₹3.7t | ₹377.9b | 27.7x | 37.3x | 3.8x |
| Mon, 17 Oct 2022 | ₹13.8t | ₹3.6t | ₹360.0b | 25.5x | 38.4x | 3.9x |
| Wed, 14 Sep 2022 | ₹13.8t | ₹3.6t | ₹361.5b | 26.1x | 38.1x | 3.8x |
| Fri, 12 Aug 2022 | ₹13.8t | ₹3.6t | ₹366.6b | 23.1x | 37.6x | 3.9x |
| Sun, 10 Jul 2022 | ₹13.2t | ₹3.5t | ₹376.5b | 22.2x | 35.1x | 3.7x |
| Tue, 07 Jun 2022 | ₹13.1t | ₹3.5t | ₹375.5b | 22.8x | 34.8x | 3.7x |
Price to Earnings Ratio
34.8x
Current Industry PE
- Investors are relatively neutral on the Indian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 40.8x.
- The 3-year average PS ratio of 4.6x is lower than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 25% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | 0.44% | |
| Healthcare | 0.40% | |
| Life Sciences | 2.96% | |
| Biotech | 1.41% | |
| Pharma | 0.77% | |
| Healthcare Services | -1.90% | |
| Healthtech | -3.61% | |
| Medical Equipment | -5.37% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 63.5x.
- Analysts are expecting annual earnings growth of 22.8%, which is lower than the prior year's growth of 28.4% per year.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 37.2x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 24% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 500660 GlaxoSmithKline Pharmaceuticals | ₹3.30k | 9.0% +₹46.3b | 25.3% | PE60.2x | |
| DIVISLAB Divi's Laboratories | ₹6.61k | 2.0% +₹34.2b | 53.5% | PE80.1x | |
| ONESOURCE OneSource Specialty Pharma | ₹1.92k | 14.0% +₹26.9b | n/a | PS15.2x | |
| CONCORDBIO Concord Biotech | ₹1.75k | 13.8% +₹22.2b | 19.5% | PE56.1x | |
| ZYDUSLIFE Zydus Lifesciences | ₹930.00 | 2.4% +₹21.5b | -7.0% | PE20.7x |
